Kenneth J. Kelley, Director at HALOZYME THERAPEUTICS INC (HALO), bought 20,000 shares at $5.70 ($114K) on 2012-08-27, disclosed to the SEC on 2012-08-28.
Open-market purchase of $114k HALO by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| HALO | SELL | 2021-02-01 | $469K | — | Filing → |
| HALO | SELL | 2021-01-04 | $417K | — | Filing → |
| HALO | SELL | 2020-12-07 | $1.4M | — | Filing → |